Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
61 studies found for:    cardiogenic shock
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial
Condition: Cardiogenic Shock
Intervention: Device: HeartMate PHP
2 Recruiting Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction
Conditions: Acute; Myocardial Infarction, Complications;   Cardiogenic Shock
Intervention: Procedure: Mild hypothermia
3 Recruiting Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock
Conditions: Cardiogenic Shock;   Acute Myocardial Infarction;   Complications
Interventions: Procedure: Immediate multivessel PCI;   Procedure: Culprit Lesion only PCI
4 Recruiting Danish Cardiogenic Shock Trial
Conditions: Cardiogenic Shock Acute;   Acute Myocardial Infarction
Interventions: Device: Conventional circulatory support;   Device: Impella cVAD
5 Completed Intraaortic Balloon Pump in Cardiogenic Shock II
Conditions: Myocardial Infarction;   Shock, Cardiogenic
Intervention: Device: Intraaortic balloon pump
6 Terminated Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic Shock
Conditions: Myocardial Infarction;   Shock, Cardiogenic
Intervention: Device: Extra-Corporeal Life Support -Impella 2.5
7 Recruiting Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock
Condition: Cardiogenic Shock
Intervention: Drug: epinephrine/norepinephrine
8 Recruiting ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock
Condition: Cardiogenic Shock, Extracorporeal Membrane Oxygenation
Interventions: Device: Veno-arterial extracorporeal membrane oxygenation (ECMO);   Other: Early conservative therapy according to standard practice
9 Completed Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock
Condition: Shock, Cardiogenic
Intervention: Drug: Abciximab
10 Not yet recruiting Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Condition: Acute Myocardial Infarction
Interventions: Drug: Single bolus of Placebo of CicloMulsion® (Neurovive).;   Drug: Single bolus of cyclosporine A (CicloMulsion®, Neurovive)
11 Completed CardShock Study and Registry
Condition: Cardiogenic Shock
Intervention:
12 Completed The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)
Conditions: Cardiogenic Shock,;   With ECMO or IABP Support,;   With APACH II Score >25)
Intervention:
13 Completed Aortic Balloon Counterpulastion in Myocardial Infarction Related Shock
Conditions: Myocardial Infarction;   Cardiogenic Shock
Intervention: Device: Intra-aortic balloon pump counterpulsation
14 Terminated A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
Condition: Shock, Cardiogenic
Intervention: Drug: Tilarginine Acetate Injection intravenous infusion
15 Completed Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation
Conditions: Shock, Cardiogenic;   Heart Failure;   Acute Myocardial Infarction
Intervention: Drug: Pyruvate
16 Completed Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)
Conditions: Shock, Cardiogenic;   Myocardial Infarction
Interventions: Device: Left Ventricular Assist Device Impella LP 2.5;   Device: Intraaortic Balloon Pump
17 Recruiting Oxidant-antioxidant Activity, Free Radicle Activity, Immune Response and Biomarkers in Extracorporeal Membrane Oxygenation (ECMO) Patients
Conditions: Cardiogenic Shock;   Acute Myocardial Infarction;   Myocarditis;   Cardiomyopathy
Intervention:
18 Unknown  Skeletal Muscle Oxygenation in Critically Ill
Conditions: Heart Failure;   Sepsis;   Septic Shock;   Cardiogenic Shock
Intervention: Device: NiRS measurment of tissue oxygenation
19 Completed Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
Conditions: Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Infarction;   Myocardial Ischemia;   Shock, Cardiogenic
Interventions: Procedure: angioplasty, transluminal, percutaneous coronary;   Procedure: coronary artery bypass;   Drug: thrombolytic therapy
20 Terminated A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI)
Condition: Myocardial Infarction
Interventions: Drug: Tenecteplase;   Procedure: PCI

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years